You are here

Home

Clinical Trials: Kidney Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, May 6, 2021 - 12:00
Classification, Functional Stratification and Biomarkers in Ciliopathy (CILLICORIRCM)
Conditions:   Ciliopathies;   Nephronophthisis;   Senior-Loken Syndrome;   Joubert Syndrome;   Jeune Syndrome;   Bardet-Biedl Syndrome
Interventions:   Other: Blood sample;   Other: Urine sample
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting
Posted: Tuesday, March 9, 2021 - 12:00
lncRNAs as a Biomarker to Assess the Therapeutic Impact of Oral Absorbent ± Probiotics in CKD Patients With PAD
Conditions:   CKD;   PAD
Intervention:   Dietary Supplement: Active bamboo charcoal± probiotics
Sponsor:   National Taiwan University Hospital
Recruiting
Posted: Thursday, February 25, 2021 - 12:00
Renin Angiotensin System Blockade in Renal Transplant Patients With Presence of PECs in Urine
Condition:   Chronic Kidney Allograft Nephropathy
Intervention:   Drug: Valsartan 80Mg Oral Tablet
Sponsor:   Josep M Cruzado
Recruiting
Posted: Monday, October 19, 2020 - 12:00
Stem Cells for Uremic Calciphylaxis Patients
Conditions:   Chronic Kidney Diseases;   Calciphylaxis;   Calcific Uremic Arteriolopathy;   Treatment
Intervention:   Other: Human amniotic mesenchymal stem cells
Sponsor:   Ningning Wang
Recruiting
Posted: Thursday, September 24, 2020 - 12:00
Clinical Research of UC-MSCs in the Treatment of Diabetic Nephropathy
Condition:   Diabetic Nephropathy
Interventions:   Drug: UC-MSCs;   Drug: Placebo
Sponsors:   Renmin Hospital of Wuhan University;   Wuhan Hamilton Biotechnology Co., Ltd
Recruiting
Posted: Wednesday, June 24, 2020 - 12:00
A Study of Cell Therapy in COVID-19 Subjects With Acute Kidney Injury Who Are Receiving Renal Replacement Therapy
Conditions:   COVID-19;   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting
Posted: Monday, May 18, 2020 - 12:00
AMSC for Reducing Anastomotic Stenosis in Primary Arteriovenous Anastomoses
Condition:   End Stage Renal Disease
Intervention:   Drug: Adipose Derived Mesenchymal Stem Cells
Sponsor:   Albert Hakaim
Not yet recruiting
Posted: Friday, January 3, 2020 - 12:00
Clinical Study of Umbilical Cord Mesenchymal Stem Cells in the Treatment of Type 2 Diabetic Nephropathy
Condition:   Type 2 Diabetes With Renal Manifestations
Interventions:   Biological: human umbilical cord mesenchymal stem cells;   Other: saline
Sponsor:   Shanghai East Hospital
Recruiting
Posted: Wednesday, December 11, 2019 - 12:00
Clinical Trial of Mesenchymal Stem Cells in the Treatment of Severe Acute Kidney Injury
Conditions:   Acute Kidney Injury;   Mesenchymal Stem Cells
Interventions:   Biological: Mesenchymal stem cells;   Other: Saline
Sponsor:   Chinese PLA General Hospital
Not yet recruiting
Posted: Thursday, December 5, 2019 - 12:00
Cell-based Therapy for the Treatment of Kidney Disease
Condition:   Kidney Diseases
Intervention:   Biological: endothelial progenitor cell
Sponsor:   Brigham and Women's Hospital
Not yet recruiting

Pages